Incidence of preeclampsia and fetal growth restriction among antenatal women with normal uterine artery Doppler at 11-14 weeks
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20261603Keywords:
First trimester, Preeclampsia, Fetal growth restriction, Uterine artery Doppler, Pulsatility indexAbstract
Background: Preeclampsia remains a leading contributor to maternal morbidity and mortality worldwide, while fetal growth restriction is associated with an increased risk of adverse neonatal outcomes, including preterm birth, low birth weight, and long-term developmental challenges. Early prediction and prevention of these conditions are crucial for improving maternal and fetal outcomes. This study aims to estimate the incidence of preeclampsia and fetal growth restriction in antenatal women with normal uterine artery Doppler at 11-14 weeks.
Methods: A prospective observational study for a period of one and a half year, clinical data and demographic data were collected, analysed and the p-value will be calculated by the Pearson Chi-square test. The significance level will be set a p<0.05.
Results: Despite normal uterine artery Doppler indices at 11–14 weeks, the study population showed a 7.3% incidence of preeclampsia and 36% fetal growth restriction. These women also had higher risks of small-for-gestational-age neonates, gestational hypertension, and diabetes. Maternal age, body mass index (BMI), socioeconomic status, education, and parity were significantly associated with adverse outcomes, and fetal growth restriction was notably linked to preeclampsia.
Conclusion: The study highlights that even with normal uterine artery Doppler PI at 11–14 weeks, women remain at risk for preeclampsia and fetal growth restriction. Early identification and monitoring, including aspirin therapy and attention to borderline PI values, may help prevent adverse outcomes. The findings support further research combining Doppler with biochemical markers for improved early prediction.
References
Cunningham F, Leveno KJ, Dashe JS, Hoffman BL, Spongy CY, Casey BM. Williams Obstetrics. 26th edition. Chapter 40: McGraw Hill. 2022;688-703.
Halder A, Jose R, Vijayselvi R. Maternal mortality and derivations from the WHO near-miss tool: An institutional experience over a decade in Southern India. J Turk Ger Gynecol Assoc. 2014;15(4):222-7.
Oancea M, Grigore M, Ciortea R, Diculescu D, Bodean D, Bucuri C, et al. Uterine Artery Doppler Ultrasonography for First Trimester Prediction of Preeclampsia in Individuals at Risk from Low-Resource Settings. Med Kaunas Lith. 2020;56(9):428.
Poon LCY, Karagiannis G, Leal A, Romero XC, Nicolaides KH. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13 weeks. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2009;34(5):497-502.
Khong SL, Kane SC, Brennecke SP, da Silva Costa F. First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications. Dis Markers. 2015;2015:679730.
Gupta U, Namdeo P, Patel N. Role of Uterine Artery Doppler at 11-14 Weeks of Pregnancy in Early Prediction of Preeclampsia: A Prospective Cohort Study. J Clin Diagn Res. 2022;16(7):QC06-9.
Jabeen SS, Raoof M, Mumtaz F, Khan B, Shaheen Z. Intrauterine Growth Restriction Among Pregnant Hypertensive Women of Urban and Rural Areas. Pak J Med Dent. 2023;12(3):29-35.
Iijima T, Obata S, Miyagi E, Aoki S. Clinical Features of Preeclampsia Preceded by Fetal Growth Restriction. Cureus. 2023:15(12).
Kiran C, Madhu N. A cross-sectional observational study on rural insights: maternal body metrics, pre-pregnancy body mass index, and fetal development. Student’s J Health Res Africa. 2024;5(3):6.
Orós M, Lorenzo M, Serna MC, Siscart J, Perejón D, Salinas-Roca B. Obesity in Pregnancy as a Risk Factor in Maternal and Child Health—A Retrospective Cohort Study. Metabolites. 2024;14(1):56.
Coban U, Takmaz T, Unyeli OD, Ozdemir S. Adverse Outcomes of Preeclampsia in Previous and Subsequent Pregnancies and the Risk of Recurrence. Sisli Etfal Hastan Tip Bul. 2021;55(3):426-31.
Gottardi E, Lecarpentier E, Villette C, Berman A, Redel D, Tsatsaris V, et al. Preeclampsia before 26 weeks of gestation: Obstetrical prognosis for the subsequent pregnancy. J Gynecol Obstet Hum Reprod. 2021;50(3):102000.
Souidan I, Abdel Salam H. US Doppler and Power Doppler Prediction of Recurrent Fetal Growth Restriction. Prospective Cohort Study. Evid Based Womens Health J. 2022;12(4):319-25.
Ananth CV, Kaminsky L, Getahun D, Kirby RS, Vintzileos AM. Recurrence of fetal growth restriction in singleton and twin gestations. J Matern Fetal Neonatal Med. 2009;22(8):654-61.
Jia D, Sun F, Han S, Lu L, Sun Y, Song Q. Adverse outcomes in subsequent pregnancies in women with history of recurrent spontaneous abortion: A metaanalysis. J Obstet Gynaecol Res. 2024;50(3):281-97.
Valdimarsdottir R, Vanky E, Elenis E, Lindström L, Junus K, Jonsson M, et al. Polycystic ovary syndrome and risk of pre‐eclampsia: A national register‐based cohort study. BJOG Int J Obstet Gynaecol. 2024;131(7):985-95.
Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health. 2001;91(3):436-40.
Downloads
Published
How to Cite
Issue
Section
